Boehringer Ingelheim

Duluth, Georgia 30096

View All From Boehringer Ingelheim - Page 20
Kemin appoints key account manager
Boehringer Ingelheim posts 8.3% growth in first half of 2009
Novus crea equipo de mercadotecnia en biológicos
Q&A: Vaccinating to beat PCV2
A test-bed rig is used to demonstrate water addition, in a presentation to a group of British veterinarians.
Less labour in vaccination
0811 Pigi Vaccinate3 Opt(1)
Do benefits outweigh costs of vaccination?
0803 Pi Gfinancial
A panorama of production costs: financial effects of a health challenge
Problem solved? Real hope that wasting disease may finally be controlled has been raised by the new PCV2 vaccines now emerging to fight the diseases associated with porcine circovirus infections.
Circovirus: Now for the good news
Possible divestiture of Merck Animal Health units
BIVI announces 2009 PRRS Research Award recipients
BIVI hires Pistorius, Buller as swine division brand managers
Updates on companies - 2008
Previous Page
Page 20 of 21
Next Page
Fill out the form below to request more information about Boehringer Ingelheim
Key Contact
David Fish